Poll: Americans Aghast Over Drug Costs But Aren鈥檛 Holding Their Breath For A Fix
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation鈥檚 capital, according to the Kaiser Family Foundation.
The independent source for health policy research, polling, and news.
1,781 - 1,800 of 1,841 Results
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation鈥檚 capital, according to the Kaiser Family Foundation.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the problems that are making congressional efforts to pass legislation to stabilize the individual insurance market a long shot.
KHN correspondent Shefali Luthra answered a wide variety of questions about health care in a Reddit 鈥淎sk Me Anything鈥 chat.
The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn鈥檛 worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.
Incentives to encourage health care consumers to shop around gain momentum as a means to rein in spending.
California鈥檚 health insurers trotted out a heart-healthy character with an ulterior motive 鈥 taking a dig at drugmakers.
Hospitals increasingly team up with lending institutions to offer low- or no-interest loans to patients to make sure their bills get paid. But critics say the complexity of hospital pricing means consumers should be cautious.
The agreement would add $2 billion to the National Institutes of Health and fund community health centers around the country. But it does not include provisions to help stabilize the federal health law鈥檚 marketplaces.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?
The economy and jobs tend to eclipse health care as the top voter concern in competitive congressional and gubernatorial races.
Agencies sometimes turn away Medicare beneficiaries with chronic health problems by incorrectly claiming Medicare won't pay for their services, say patient advocates.
In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry鈥檚 agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Proponents say the proposed regulation will give some consumers more affordable insurance options. Critics warn that the coverage could be less comprehensive.
In this episode of 鈥淲hat The Health?鈥 Julie Rovner of Kaiser Health News, Paige Winfield Cunningham of The Washington Post, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss this week鈥檚 news, including release of the administration鈥檚 new rules on association health plans, as well as some health-related court rulings and other events that happened around the holidays.
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn鈥檛 make those changes in the current tax bill.
In this episode of 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Stephanie Armour of the Wall Street Journal, Alice Ollstein of Talking Points Memo and Margot Sanger Katz of The New York Times discuss new health spending numbers from the federal government, as well as how the year-end legislating in Congress is being complicated by health issues.
Medicines are up to 80 percent cheaper north of the border and overseas, so U.S. localities are greasing a pharmaceutical pipeline that the feds warn is illegal and possibly unsafe.
漏 2026 KFF